Literature DB >> 23822556

Synthesis and biological evaluation of a new series of highly functionalized 7'-homo-anhydrovinblastine derivatives.

Olga Gherbovet1, Claire Coderch, María Concepción García Alvarez, Jérôme Bignon, Sylviane Thoret, Marie-Thèrese Martin, Françoise Guéritte, Federico Gago, Fanny Roussi.   

Abstract

Sixteen new 7'-homo-anhydrovinblastine derivatives were prepared in one or two steps from vinorelbine by means of an original and regiospecific rearrangement and subsequent diastereoselective reduction. This strategy has allowed fast access to a family of vinca alkaloid derivatives with an enlarged and functionalized ring C'. Their synthesis and biological evaluation are reported. One compound (compound 35) is 1.7 times more active than vinorelbine as a tubulin assembly inhibitor. Moreover, some of these compounds are highly cytotoxic, and two of them are more potent than vinorelbine on HCT116 and K562 cell lines. Molecular modeling studies, carried out with two of the new vinca derivatives, provide useful hints about how a given functionalization introduced at positions 7' and 8' of the C' ring results in improved binding interactions between one of the new derivatives and the interdimer interface when compared to the parent compound vinblastine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23822556     DOI: 10.1021/jm4004347

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Potent Vinblastine C20' Ureas Displaying Additionally Improved Activity Against a Vinblastine-Resistant Cancer Cell Line.

Authors:  Timothy J Barker; Katharine K Duncan; Katerina Otrubova; Dale L Boger
Journal:  ACS Med Chem Lett       Date:  2013-09-09       Impact factor: 4.345

Review 2.  Total synthesis of vinblastine, related natural products, and key analogues and development of inspired methodology suitable for the systematic study of their structure-function properties.

Authors:  Justin E Sears; Dale L Boger
Journal:  Acc Chem Res       Date:  2015-01-14       Impact factor: 22.384

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.